Coexpression of FAS and FAS-ligand in chronic pancreatitis: Correlation with apoptosis

Pancreas

Volumn 20, Issue 2, 2000, Pages 123-128

  Kornmann, Marko ^a   Ishiwata, Toshiyuki ^a   Maruyama, Haruhisa ^a   Beger, Hans G ^b   Korc, Murray ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF ULM   (Germany)

Author keywords

Apoptosis; Chronic pancreatitis; Fas; FasL; Pancreas

Indexed keywords

FAS ANTIGEN; FAS LIGAND;

ADULT; APOPTOSIS; ARTICLE; CHRONIC PANCREATITIS; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ADULT; ANTIGENS, CD95; APOPTOSIS; BLOTTING, NORTHERN; CHRONIC DISEASE; FAS LIGAND PROTEIN; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; PANCREAS; PANCREATITIS;

EID: 0033993647     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006676-200003000-00003     Document Type: Article

References (30)

1. Itoh N, Yonehara S, Ishii A, et al. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 1991;66:233-43.
2. Nagata N, Golstein P. The Fas death factor. Science 1995;267: 1449-56.
3. Cifone MG, De Maria R, Roncaioli P, et al. Apoptotic signaling through CD95 (Fas/Apo-1) activates an acidic sphingomyelinase. J Exp Med 1994;180:1547-52.
4. Suda T, Takahashi T, Golstein P, Nagata S. Molecular cloning and expression of the Fas ligand: a novel member of the tumor necrosis factor family. Cell 1993;75:1169-78.
5. Depraetere V, Golstein P. Fas and other cell death signaling pathways. Semin Immunol 1997;9:93-107.
6. O'Connell J, O'Sullivan GC, Collins JK, Shanahan F. The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand. J Exp Med 1996;184:1075-82.
7. Shiraki X, Tsuji N, Shioda T, Isselbacher KJ, Takahashi H. Expression of Fas ligand in liver metastases of human colonie adenocarcinomas. Proc Natl Acad Sci U S A 1997;94:6420-5.
8. Von Reyher U, Strater J, Kittstein W, Gschwendt M, Krammer PH, Moller P. Colon carcinoma cells use different mechanisms to escape CD95-mediated apoptosis. Cancer Res 1998;58:526-34.
9. Gutierrez-Steil C, Wrone-Smith T, Sun X, Krueger JG, Coven T, Nickoloff BJ. Sunlight-induced basal cell carcinoma tumor cells and ultraviolet-B-irradiated psoriatic plaques express Fas ligand (CD95L). J Clin Invest 1998;101:33-9.
10. Martinez-Lorenzo MJ, Gamen S, Etxeberria J, et al. Resistance to apoptosis correlates with a highly proliferative phenotype and loss of Fas and CPP32 (caspase-3) expression in human leukemia cells. Int J Cancer 1998;75:473-81.
11. Ungefroren H, Voss M, Janssen M, et al. Human pancreatic adenocarcinomas express Fas and Fas ligand yet are resistant to Fas-mediated apoptosis. Cancer Res 1998;58:1741-9.
12. Oertel JE, Heffess CS, Oertel YC. Pancreas. In: Sternberg SS, ed. Diagnostic surgical pathology. New York: Raven Press, 1989: 1057-93.
13. Friess H. Korc M, Büchler MW. Growth factors and growth factor receptors in chronic pancreatitis. In: Beger HG, Büchler MW, Schoenberg MH, eds. Cancer of the pancreas. Ulm, Germany: Universitätsverlag Ulm GmbH, 1996:143-50.
14. Ishiwata T, Kornmann M, Beger HG, Korc M. Enhanced fibroblast growth factor 5 expression in stromal and exocrine elements of the pancreas in chronic pancreatitis. Gut 1998;43:134-9.
15. Kornmann M, Ishiwata T, Beger HG, Korc M. Fibroblast growth factor-5 stimulates mitogenic signaling and is overexpressed in human pancreatic cancer: evidence for autocrine and paracrine actions. Oncogene 1997;15:1417-24.
16. Rehemutulla A, Hamilton CA, Chinnaiyan AM, Dixit VM. Ultraviolet radiation-induced apoptosis is mediated by activation of CD-95 (Fas/APO-1). J Biol Chem 1997;272:25783-6.
17. Fulda S, Sieverts H, Friesen C, Herr I, Debatin K-M. The CD95 (APO-1/Fas) system mediates drug-induced apoptosis in neuroblastoma cells. Cancer Res 1997;57:3823-9.
18. Giordano C, Stassi G, De Maria R, et al. Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis. Science 1997;275:960-3.
19. Törmänen U, Eerola A-K, Rainio P, et al. Enhanced apoptosis predicts shortened survival in non-small cell lung cancer. Cancer Res 1995;55:5595-602.
20. Wright AS, Thomas LN, Douglas RC, Lazier CB, Rittmaster RS. Relative potency of testosterone and dihydrotestosterone in preventing atrophy and apoptosis in the prostate of the castrated rat. J Clin Invest 1996;98:2558-63.
21. Cheng J, Zhou T, Changdan L, et al. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science 1994; 263:1759-62.
22. Nagata S. Apoptosis by death factor. Cell 1997;88:355-65.
23. Pan G. O'Rourke K, Chinnaiyan AM, et al. The receptor for the cytotoxic ligand TRAIL. Science 1997;276:111-3.
24. Chaudhary PM, Eby M, Jasmin A, Bookwalter A, Murray J, Hood L. Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF-kappaB pathway. Immunity 1997;7:821-30.
25. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995;267:1456-62.
26. Zhang H, Yang Y, Horton JL, et al. Amelioration of collagen-induced arthritis by CD95 (Apo-1/Fas)-ligand gene transfer. J Clin Invest 1997;100:1951-7.
27. Luo KX, Zhu YF, Zhang LX, He HT, Wang XS, Zhang L. In situ investigation of Fas/FasL expression in chronic hepatitis B infection and related liver diseases. J Viral Hepatitis 1997;4:303-7.
28. Dowling P, Shang G, Raval S, Menonna J, Cook S, Husar W. Involvement of the CD95 (APO-1/Fas) receptor/ligand system in multiple sclerosis brain. J Exp Med 1996;184:1513-8.
29. Green DR, Ware CF. Fas-ligand: privilege and peril. Proc Natl Acad Sci U S A 1997;94:5986-90.
30. Golstein P, Marguet D, Depraetere V. Fas bridging cell death and cytotoxicity: the reaper connection. Immunol Rev 1995;146:45-56.